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Abstract
Host genetic variants are known to confer resistance to Plasmodium blood stage infection and to control malaria severity
both in humans and mice. This work describes the genetic mapping of a locus for resistance to liver stage parasite in the
mouse. First, we show that decreased susceptibility to the liver stage of Plasmodium berghei in the BALB/c mouse strain is
attributable to intra-hepatic factors and impacts on the initial phase of blood stage infection. We used QTL mapping
techniques to identify a locus controlling this susceptibility phenotype (LOD score 4.2) on mouse chromosome 17 (belr1
locus). Furthermore, analysis of congenic mouse strains delimited the belr1 locus boundaries distally to the H2 region.
Quantification of parasites in the liver of infected congenic mice strongly suggested that the belr1 locus represents a genetic
factor controlling the expansion of P. berghei in the hepatic tissue. The mapping of belr1 locus raises the hypothesis that
host gene variation is able to control the progression of Plasmodium liver stage infection and opens the possibility that the
human genomic region orthologue to belr1 may contain genes that confer resistance to the human malaria liver stage.
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Introduction
Malaria is caused by the hematoprotozoan of the genus
Plasmodium and provides one of the best examples of how positive
selective pressure upon host genetic variants may confer resistance
to disease. For example, the mutation underlying sickle cell anemia
conferred resistance to malaria (cited in [1]) other erythrocyte
traits such as G6PD deficiency, alpha-thalassemia and hemoglobin
C are thought to have beneficial effects by reducing parasite
invasion or growth in the erythrocytes or by facilitating the
elimination of infected erythrocytes (reviewed in [2]). More
recently, genome-wide analysis using inbred mouse strains has
revealed that a considerable number of chromosomal regions that
enhance control of infection with different Plasmodium species
(reviewed in ([3]).
Genetic analysis of infection with P. chabaudi infection has
identified nine loci that contribute to control of the parasitemia
(char1–9) [3,4]. Analysis of recombinant mouse strains allowed the
dissection of multipartite loci in char2 [5,6], char3 [7] and char4 [8]
regions and to the identification of positional candidate genes for
the char9 locus [9]. In particular, a mutation in the pyruvate kinase
gene has been identified as mediating a protective mechanism to
P.chabaudi infection involving increased splenic clearance of
erythrocytes through hemolysis [10,11].
Similarly, resistance to cerebral malaria caused by P. berghei
infection was mapped to four loci (berr1, berr2, cmsc and a locus on
chromosome 18) [12–14]. In addition, genetic analysis of the
course of P. berghei infection identified a locus that controls the
resistance to lethal infection (berr3) and a locus enhancing survival
time (berr4) [15]. Parasite clearance and survival to P. berghei
infection was attributed to a combinatorial effect of berr1 and berr3
loci, illustrating that resistance to infection may arise from genetic
interaction among host resistance factors [15,16].
Many malaria-related traits have been analyzed but the role of
genetic variants in controlling liver infection has not been
addressed. During the initial liver stage of infection, individual
sporozoites infect hepatocytes and grow to large schizonts that
finally differentiate into 10,000–40,000 merozoites that are
released in the bloodstream and infect the red blood cells. A
major obstacle to genetic studies in man is the fact that the liver
stage infection is largely asymptomatic. Genetic studies in the
mouse were initially focused on evaluating the role of MHC alleles
in conferring protection induced by irradiated sporozoites [17].
More recently, analysis of knockout mouse models has proved the
involvement of host genes like CD81 in the malaria liver stage
[18]. As early observations suggested that natural genetic variance
between mouse strains may underlie differences in susceptibility to
infection with Plasmodium sporozoites [19] we have conducted a
genetic mapping study to identify genetic factors controlling the
liver stage of infection. We report that a quantitative trait locus
(belr1) mapping to mouse chromosome 17 partially controls
expansion of P.berghei sporozoites during liver infection.
Results
Course of liver stage infection
Early reports suggest that infection of BALB/c mice with
P.berghei sporozoites resulted in low level of hepatocyte infection at
the end of the liver stage (44 h post-infection) [19]. We quantified
P.berghei 18S rRNA in the liver during the course of infection in
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injection. No difference was observed between the two mouse
strains during the initial phase of infection but from 24 h up to
40 h post-infection the parasite burden in BALB/c mice was
significantly lower (Figure 1). Given that sporozoites invade the
liver in less than 1 h, this result suggested that the low parasite
expansion in BALB/c mice was controlled within the liver. Next,
we quantified the parasite burden in liver of BALB/c and C57BL/
6 mice infected by intra-hepatic injection (Figure 2). Once again
the parasite burden was lower in BALB/c mice confirming that
the poor expansion of P.berghei in BALB/c mice was attributable to
intra-hepatic factors.
Liver stage susceptibility phenotype
Blood smear analysis of parasitemia rising after sporozoite
injection showed that BALB/c mice displayed lower parasitemia
than C57BL/6 mice on days 4 and 5 after infection (Figure 3),
suggesting that the decreased parasite expansion in the BALB/c
delays the development of blood stage infection. Thus, we used
parasitemia at day 5 post-infection as an assay to assess the
previously occurring parasite expansion in the liver. We studied
the segregation of the day-5 parasitemia phenotype in genetic
crosses of BALB/c and C57BL/6 mice and we observed that the
first generation crosses showed an intermediate phenotype
(Figure 3) and that the phenotypic spectrum of the second
generation progeny indicated that alleles controlling the pheno-
type were segregating in the (C57BL/6 X BALB/c) F2 cross. The
phenotype in the 115 F2 progeny approached a normal
distribution suggesting that could be analyzed as a quantitative
trait (Figure 4).
Figure 1. Reduced expansion of P. berghei in BALB/c liver after
intravenous injection. P. berghei 18S rRNA was quantified by real-
time PCR in the liver of C57BL/6 and BALB/c males at the indicated
times after intravenous injection of 10
4 P. berghei sporozoites. Each data
point represents the average value and standard deviation of parasite
quantification in the liver of 5–10 mice. Differences between groups
were evaluated by unpaired t-test (** p,0.01).
doi:10.1371/journal.pone.0001874.g001
Figure 2. Reduced expansion of P. berghei in BALB/c liver after
intra-hepatic injection. C57BL/6 and BALB/c mice were surgically
injected under the liver capsule with 10
4 P. berghei sporozoites and
compared with mice injected intravenously. P. berghei 18S rRNA was
quantified by real-time PCR at 40 hours after injection. Average values
and standard deviations for each experimental group are represented.
Differences between groups were evaluated by unpaired t-test (* p,
0.05, ** p,0.01).
doi:10.1371/journal.pone.0001874.g002
Figure 3. The liver stage susceptibility trait. Parasitemia was
measured at day 5 post-infection with 10
4 P. berghei sporozoites in 10
C57BL/6 (dark squares), 12 BALB/c (white squares), 11 (C57BL/6 X BALB/
c) F1 (inverted triangles) and 11 (BALB/c X C57BL/6) F1 (diamonds).
Group averages are shown as horizontal bars.
doi:10.1371/journal.pone.0001874.g003
Figure 4. Variance of liver stage susceptibility trait. Frequency
distribution of parasitemia at day 5 post-infection in the 115 (C57BL/6 X
BALB/c) F2 genotyped in this study. The observed frequencies are
represented in bars, and the predicted t-distribution curve is
superimposed.
doi:10.1371/journal.pone.0001874.g004
Malaria Liver Stage Genetics
PLoS ONE | www.plosone.org 2 March 2008 | Volume 3 | Issue 3 | e1874Genetic mapping of liver susceptibility phenotype
In order to map the gene(s) controlling the parasite expansion in
the liver, we used 93 microsatellite markers across the whole
genome and scanned for quantitative trait loci (QTL) in the 115
(C57BL/6 X BALB/c) F2 progeny. Using QTL statistical analysis,
significant linkage was found to the medial region of chromosome
17, where the highest linked marker D17Mit20 reached a LOD
score of 4.2 (Figure 5). No other region in the genome reached the
genome-wide level of significance, but markers on distal
chromosome 1 have shown suggestive linkage (LOD score 2.73),
raising the possibility that a second locus mapping in this region
may also contribute to the phenotype. The mapped locus in
chromosome 17 was named belr1 locus (berghei liver resistance) and
the genetic effect of the highest linked marker (D17Mit20) was
estimated to explain 15.4% of phenotypic variance observed in the
F2 progeny.
Congenic mapping of belr1 locus
To confirm the genetic mapping of the belr1 locus we analyzed
the decreased susceptibility to liver infection in congenic strains
containing defined chromosome 17 segments of one parental
strain introgressed in the background of the other parental strain.
The B6.C-H2d congenic strain carries a 38 Mb segment of
BALB/c chromosome 17 encompassing the H2 locus in the
genetic background of the C57BL/6 strain. Conversely, the
C.B10-H2b strain carries the H2b haplotype in the BALB/c
genetic background. We found that the B6.C-H2d strain showed
decreased parasite burden in the liver, indicating that the genetic
factor mediating the belr1 effect is contained in this congenic
region (Figure 6A). In contrast, C.B10-H2b mice showed liver-
stage resistance similar to BALB/c mice (Figure 6B). These results
demonstrate that the H2b haplotype per se is not controlling the
liver burden phenotype, and strongly suggest that the belr1 locus is
mapping distally to the H2 locus. The combined analysis of the
congenic strains confines the belr1 locus to a region of 28 Mb on
chromosome 17 distal to the H2 locus (Figure 7). As an alternative
approach, we performed a conditional analysis in the F2 progeny
that fixed the H2 genetic effect by using the D17MIT233 marker
as a co-variate in the QTL analysis. Under this analysis the LOD
score curve still persisted on the belr1 locus albeit with lower values.
These results suggest that the belr1 genetic effect is independent of
the H2 locus, but do raise the possibility that genes in the H2d
haplotype present in the B6.C-H2d mouse strain may also
contribute to the malaria liver-stage resistance.
Collectively, the results indicate that a genetic factor(s)
controlling susceptibility to liver infection by P. berghei is located
in the belr1 locus and acts at the intra-hepatic level to control
parasite liver stage expansion.
Discussion
The key observation in this work is the demonstration that the
belr1 locus controls the expansion of P. berghei in the liver, and that
impacts on the level of subsequent blood parasitemia. Using mouse
congenic strains the locus controlling parasite expansion in the
liver was delimited within an interval of 28 Mb on mouse
chromosome 17 close to the MHC locus previously linked to
malaria resistance in both man and mouse. Although this analysis
indicated that the major genetic effect on chromosome 17 maps
outside the H2 region it is still possible that the H2 locus could
contribute to the observed phenotype. In addition, genetic markers
in distal chromosome 1 suggest that a second locus could also be
involved in the genetic control of this phenotype. Incidentally, this
region coincides with a locus (berr1), that we have previously shown
to control cerebral malaria and parasitemia clearance following P.
berghei ANKA infection [12,15]. To further dissect such multiple
genetic effects will include the generation and analysis of
subcongenic strains carrying different congenic intervals derived
form the B6.C–H2d mouse strain.
The possible involvement of the MHC region in the genetic
control of resistance to malaria resistance in humans has
stimulated a search for the contribution of the MHC and TNF
molecules to the pathogenesis of malaria. For example, a
significant number of reports claim genetic linkage and allelic
association of these genes with severe forms of disease and re-
Figure 5. Genome-wide mapping of liver stage susceptibility trait. LOD score curves representing the likelihood for linkage of parasite
burden trait. Genome-wide linkage is significant for LOD score above 3.3. (A) Shows LOD score curves for 19 mouse autosomes. (B) Shows LOD score
curve for chromosome 17 where the X-axis ticks represent the relative position of microsatellite markers. Markers from left to right: D17Mit62;
D17Mit103; D17Mit233; D17Igc1; D17Mit24; D17Mit11; D17Igc2; D17Igc3; D17Mit139; D17Mit20; D17mit152; D17Mit193; D17Mit187; D17Mit221.
doi:10.1371/journal.pone.0001874.g005
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whether the genetic effects presented in these studies could result
from genetic factors mapping just outside the MHC region like the
belr1 locus. It is of immediate interest to evaluate the human
orthologue to belr1 region to malaria genetic resistance in humans
through unbiased association mapping studies.
Previous genetic analysis determined that mouse chromosome
17 contains loci exerting weak control of resistance to P. chabaudi
parasitemia [25] , in particular the H2-linked locus, char3, which
mediates delayed parasitemia kinetics [26]. Further work suggest-
ed that these genetic effects were possibly contributed by an
additional locus, char7, mapping distally to the H2 in a region that
co-localizes with belr1 locus [7]. Thus, it remains to be determined
whether the locus described in this report coincides with char7
locus, thereby representing a genetic factor controlling malaria
infection at both liver and blood stages and having a relevant role
in the disease caused by different murine Plasmodium species.
The belr1 region contains 384 genes and includes known genes,
predicted genes and other ORFs. Certainly, some genes are
readily excluded from the liver resistance phenotype, as is the case
of 49 genes coding for olfactory receptors. However, the presence
of at least 80 unknown genes precludes the identification of
plausible candidates. Subcongenic mapping will be performed to
narrow down the number of credible positional candidate genes
which will then be subjected to functional and structural analysis.
The identification of candidate genes for the belr1 locus may lead
to the characterization of similar human genetic factors playing a
role in malaria resistance by though their impact on asymptomatic
liver infection.
It is likely that cell and molecular components that are involved
in the observed host resistance exert their effect by limiting the
expansion of the parasite liver stages in the hepatic tissue, raising
the question of the underlying resistance mechanism. One
possibility is suggested by work with P. berghei [19] where the
blockage of liver-stage parasite development in BALB/c liver has
been correlated with the immediate liver inflammatory response
[27]. However, the relevant effectors and target cells have not
been defined. One attractive hypothesis is that, liver resident cell
types, such as Kupfer cells or NK and NKT cells act on the
parasite, in either extracellular or intracellular forms.
Alternatively, the observed resistance to Plasmodium expansion
could be mediated by a hepatocyte factor that controls the survival
of infected hepatocytes, for example sporozoite mediated inhibi-
tion of hepatocyte apoptosis. In fact, release of hepatocyte growth
factor (HGF) [28] and signaling through the HGF/c-Met pathway
[29] are considered as part of a chain of events that leads to
apoptosis resistance of P. berghei-infected hepatocytes [30]. It has
Figure 7. Location of belr1 locus in chromosome 17. The diagram
represents the physical map of chromosome 17 congenic regions in
B6.C-H2d and C.B10-H2b mouse strains compared to the C57BL/6 strain.
Delimitation of belr1 locus is represented taking into account the
malaria resistance phenotypes in the congenic strains.
doi:10.1371/journal.pone.0001874.g007
Figure 6. The belr1 locus controls Plasmodium liver burden. P.
berghei 18S rRNA was quantified by real-time PCR both in the livers of
parental mouse strains (C57BL/6 and BALB/c) and in B6.C-H2d congenic
mice (A) or in C.B10-H2b congenic mice (B) 40 hours after infection with
10
4 P. berghei sporozoites. The observed difference between C57BL/6
and B6.C-H2d is attributable to the congenic region in chromosome 17
of B6.C-H2d mice while the chromosome 17 congenic region in the
C.B10-H2b shows no control over malaria resistance phenotype.
Statistical significance was evaluated by unpaired t-test (* p,0.05,
** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0001874.g006
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spontaneous apoptosis mediated by HGF/c-Met signaling is
extended in time possibly by induction of additional apoptosis
resistance mechanisms [31]. We are currently testing this
possibility by studying the induction of hepatocyte apoptosis in
the presence of P. berghei sporozoites.
Searching for such cellular phenotypes in relevant congenic
strains is part of a strategy to identify the cell type(s) mediating the
belr1 effect. If successful, this approach will accelerate the
identification of the belr1 gene(s).
Materials and Methods
Mice
Parental mouse strains used in this study were C57BL/6, BALB/
c, (BALB/c X C57BL/6) F1 and (C57BL/6 X BALB/c) F1.
(C57BL/6 X BALB/c) F1micewere usedtogeneratethe (C57BL/6
X BALB/c) F2 progeny of 115 males. Two H2 congenic mouse
strains were obtained from the Jackson Laboratory (Maine, USA)
and maintained at IGC. B6.C-H2
d/bByJ carries a BALB/c-derived
congenic segment of 37.9 Mb on chromosome 17, flanked by
markers D17Mit198 and D17Mit152, on C57BL/6 genetic
background and is here referred to as B6.C-H2d. C.B10-H2
b/
LilMcdJ carries a C57Bl/10-derived segment of 10.4 Mb on
chromosome 17, flanked by markers D17Mit80 and D17Mit232,
on BALB/c genetic background and is here referred to as C.B10-
H2b. The haplotype b of H2 is common to strains C57BL/6 and
C57BL/10. All mice were bred and maintained in conventional
housing facilities at the Instituto Gulbenkian de Cie ˆncia. All
experiments used male mice with 8 to 15 weeks of age. All
procedures were in accordance with national regulations on animal
experimentation and welfare.
Infection
Plasmodium berghei ANKA sporozoites were obtained from
dissection of salivary glands from infected female Anopheles stephensi
mosquitoes. Sporozoites suspensions in RPMI medium were
injected i.v. in 100 ml inocula of 10
4 sporozoites per mouse.
To perform the intra-hepatic injection, the mice were
anesthetized with Ketamine by i.p. injection. The abdominal
cavity was surgically accessed through the medial line, partially
exposing the left liver lobe. Sporozoites were injected under the
liver capsule in a 50 ml inoculum. Then, the abdominal wall
muscles and skin were sutured, and the animals were maintained
until 40 h post-infection.
Parasite quantification
Parasitemia progression was measured at day 5 post-infection by
blood smears with Giemsa. Liver parasite 18S rRNA was
quantified by real-time PCR. Livers were collected at 40 h post-
infection, immediately homogenized in denaturing solution (4 M
guanidine thiocyanate, 25 mM sodium citrate pH 7.0, 0.5%
sarcosyl and 0.7% b-mercaptoethanol in DEPC treated water) and
total RNA was obtained using RNeasy Mini Kit (Qiagen). One
microgram of total RNA was converted to cDNA (Transcriptor
First Strand cDNA Synthesis Kit, Roche) and cDNA specific to P.
berghei 18S rRNA was amplified with primers NYU-Pb1 59-AAG
CAT TAA ATA AAG CGA ATA CAT CCT TAC-39 and NYU-
Pb2 59-GGA GAT TGG TTT TGA CGT TTA TGT-39. The
real-time PCR reactions were performed in ABI Prism 7900HT
system using ABI Power SYBR Green PCR Master Mix. Absolute
P.berghei 18S rRNA estimates were normalised for mRNA of
Hypoxanthine Guanine Phosphoribosyl-Transferase (HPRT), a
mouse housekeeping gene.
Genotyping
Genomic DNA was prepared from mouse tails before infection,
using standard techniques. The 115 (C57BL/6 X BALB/c) F2
progeny mice were genotyped by using conventional PCR
protocols for 93 microsatellite markers obtained from the
Whitehead/MIT Center for Genome Research collection (www.
genome.wi.mit.edu/cgi-bin/mouse/index). Primers for Igc mark-
ers were: D17Igc1 For GGG AGT GGG AAT TCT TTT ATT
TTA and Rev TGC TTT CTT CTG GTG TCT CTG AA;
D17Igc2 For GCT CAC TTT TTC CTA GCA TCA TC and
Rev GCC ATG GGA AGA AGT TAT ATG TC; D17Igc3 For
GAT AAG TTT GGA GTC AGG CCT AA and Rev ACT TAT
TCA CTC CTG AGC CTT GT. Individual mouse genotypes
were scored using established agarose gel electrophoresis proto-
cols.
Statistical Analysis
Quantitative trait locus analysis was performed using the R/
QTL software [32]. This program calculates logarithm of odds
(LOD) scores over intervals between linked markers, generating
LOD score curves representing the likelihood of genetic linkage of
quantitative phenotypes with markers along the chromosome. The
level of statistical significance was empirically determined by
permutation tests (5.000) and genome-wide significant linkage was
considered when LOD $3.3 (p,0.05).
Comparisons between groups of animals were considered
statistical significant when the p-value of the unpaired t-test was
,0.05.
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